U S PHYSICAL THERAPY INC /NV Variable Lease, Cost
U S PHYSICAL THERAPY INC /NV (USPH) reported Variable Lease, Cost of $2.59 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV variable lease, cost for the quarter ending 2026-06-30 was $2.59M, a 3.36% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV variable lease, cost for the quarter ending 2026-03-31 was $2.65M, a 5.13% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV variable lease, cost for the quarter ending 2025-12-31 was $2.15M, a 7.08% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV variable lease, cost for the quarter ending 2025-09-30 was $2.54M, a 0.31% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV variable lease, cost for fiscal 2025 was $9.89M, a 1.56% increase from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV variable lease, cost for fiscal 2024 was $9.74M, a 3.19% increase from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV variable lease, cost for fiscal 2023 was $9.44M, a 39.22% increase from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV variable lease, cost for fiscal 2022 was $6.78M, a 3.94% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.59M 10-Q · filed 2026-08-07 | $5.24M 10-Q · filed 2026-08-07 | $7.39M derived: sum of 3 quarters · filed 2026-08-07 | $9.93M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $2.65M 10-Q · filed 2026-05-08 | $4.79M derived: sum of 2 quarters · filed 2026-05-08 | $7.34M derived: sum of 3 quarters · filed 2026-05-08 | $10.02M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.69M derived: sum of 2 quarters · filed 2026-02-27 | $7.37M derived: sum of 3 quarters · filed 2026-08-07 | $9.89M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $2.54M 10-Q · filed 2025-11-07 | $5.22M derived: sum of 2 quarters · filed 2026-08-07 | $7.74M 10-Q · filed 2025-11-07 | $9.75M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $2.68M 10-Q · filed 2026-08-07 | $5.20M 10-Q · filed 2026-08-07 | $7.21M derived: sum of 3 quarters · filed 2026-08-07 | $9.76M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $2.52M 10-Q · filed 2026-05-08 | $4.52M derived: sum of 2 quarters · filed 2026-05-08 | $7.08M derived: sum of 3 quarters · filed 2026-05-08 | $9.75M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.56M derived: sum of 2 quarters · filed 2026-02-27 | $7.24M derived: sum of 3 quarters · filed 2026-02-27 | $9.74M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $2.55M 10-Q · filed 2025-11-07 | $2.43M 10-Q · filed 2024-11-08 | $5.23M derived: sum of 2 quarters · filed 2025-11-07 | $7.73M 10-Q · filed 2025-11-07 | $7.36M 10-Q · filed 2024-11-08 | $10.37M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | $2.68M 10-Q · filed 2025-08-08 | $2.56M 10-Q · filed 2024-08-14 | $5.14M 10-Q · filed 2025-08-08 | $4.93M 10-Q · filed 2024-08-14 | $7.81M derived: sum of 3 quarters · filed 2026-02-27 | $10.09M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | $2.48M 10-Q · filed 2025-05-09 | $2.37M 10-Q · filed 2024-05-08 | $5.14M derived: sum of 2 quarters · filed 2026-02-27 | $7.42M derived: sum of 3 quarters · filed 2026-02-27 | $9.79M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2023-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.93M derived: sum of 2 quarters · filed 2026-02-27 | $7.31M derived: sum of 3 quarters · filed 2026-02-27 | $9.44M 10-K · filed 2026-02-27 | $8.91M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $2.28M 10-Q · filed 2024-11-08 | $4.65M derived: sum of 2 quarters · filed 2024-11-08 | $6.79M 10-Q · filed 2024-11-08 | $7.73M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $2.37M 10-Q · filed 2024-08-14 | $4.50M 10-Q · filed 2024-08-14 | $5.45M derived: sum of 3 quarters · filed 2025-03-03 | $7.36M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $2.13M 10-Q · filed 2024-05-08 | $3.07M derived: sum of 2 quarters · filed 2025-03-03 | $4.99M derived: sum of 3 quarters · filed 2025-03-03 | $6.98M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $2.85M derived: sum of 2 quarters · filed 2025-03-03 | $4.85M derived: sum of 3 quarters · filed 2025-03-03 | $6.78M 10-K · filed 2025-03-03 | $6.29M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $1.91M 10-Q · filed 2023-11-08 | $3.91M derived: sum of 2 quarters · filed 2023-11-08 | $5.84M 10-Q · filed 2023-11-08 | $7.99M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $1.99M 10-Q · filed 2023-08-09 | $3.93M 10-Q · filed 2023-08-09 | $6.08M derived: sum of 3 quarters · filed 2024-02-29 | $7.75M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $1.93M 10-Q · filed 2023-05-05 | $4.08M derived: sum of 2 quarters · filed 2024-02-29 | $5.75M derived: sum of 3 quarters · filed 2024-02-29 | $7.38M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $3.82M derived: sum of 2 quarters · filed 2024-02-29 | $5.45M derived: sum of 3 quarters · filed 2024-02-29 | $7.06M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $1.67M 10-Q · filed 2022-11-08 | $3.30M derived: sum of 2 quarters · filed 2022-11-08 | $4.91M 10-Q · filed 2022-11-08 | $6.18M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $1.63M 10-Q · filed 2022-08-08 | $3.24M 10-Q · filed 2022-08-08 | $4.51M derived: sum of 3 quarters · filed 2023-02-28 | $5.95M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $1.61M 10-Q · filed 2022-05-09 | $2.88M derived: sum of 2 quarters · filed 2023-02-28 | $4.32M derived: sum of 3 quarters · filed 2023-02-28 | $5.83M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.71M derived: sum of 2 quarters · filed 2023-02-28 | $4.22M derived: sum of 3 quarters · filed 2023-02-28 | $5.75M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $1.44M 10-Q · filed 2021-11-09 | $2.95M derived: sum of 2 quarters · filed 2021-11-09 | $4.48M 10-Q · filed 2021-11-09 | $7.43M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $1.51M 10-Q · filed 2021-08-09 | $3.05M 10-Q · filed 2021-08-09 | $5.99M derived: sum of 3 quarters · filed 2021-08-09 | $7.54M derived: sum of 4 quarters · filed 2021-08-09 | ||||
| 2020-03-31 | $1.53M 10-Q · filed 2021-05-10 | $4.48M derived: sum of 2 quarters · filed 2021-05-10 | $6.03M derived: sum of 3 quarters · filed 2021-05-10 | $7.57M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $4.49M derived: sum of 2 quarters · filed 2021-03-01 | $6.04M derived: sum of 3 quarters · filed 2021-03-01 | $6.07M 10-K · filed 2021-03-01 | ||||
| 2019-09-30 | $1.55M 10-Q · filed 2020-11-06 | $1.48M 10-Q · filed 2019-11-08 | $3.09M derived: sum of 2 quarters · filed 2020-11-06 | $3.13M 10-Q · filed 2020-11-06 | $4.61M 10-Q · filed 2019-11-08 | |||
| 2019-06-30 | $1.55M 10-Q · filed 2020-08-07 | $3.13M 10-Q · filed 2020-08-07 | ||||||
| 2019-03-31 | $1.58M 10-Q · filed 2020-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |